Physician profile
Andrew Schroeder
NPI 1598152928
$1,002.86
in general payments reported to CMS, 2019-2025
15 companies · $403 in 2025
The $403 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $112 · 2021: $39.61 · 2022: $103 · 2023: $110 · 2024: $236 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $253.69 | 2022-2025 | Valtoco |
| Ucb, INC. | $192.13 | 2020-2025 | Nayzilam, Fintepla, Briviact |
| Eisai INC. | $130.97 | 2020-2022 | |
| Azurity Pharmaceuticals, INC. | $75.84 | 2022-2025 | Zonisade |
| Sk Life Science, INC. | $68.74 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $47.26 | 2024 | |
| Biocodex, INC. | $42.66 | 2024-2025 | |
| Livanova USA, INC. | $37.33 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.63 | 2025 | Ninlaro |
| Upsher-Smith Laboratories LLC | $24.55 | 2025 | |
| Silk Road Medical, INC. | $24.04 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Immedica Pharma US, INC. | $21.19 | 2025 | Ztalmy |
| Springworks Therapeutics, INC. | $18.58 | 2025 | Gomekli |
| Otter Pharmaceuticals, LLC | $18.00 | 2025 | Sympazan |
| Aquestive Therapeutics, INC. | $12.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Schroeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.